Ghana opens its own DNA laboratory and mRNA vaccine labs at Noguchi

Published
2 min read3 min listen
Photo: StatsGH chart

Ghana can now carry out DNA identification tests at home after President John Mahama commissioned a national human identification laboratory at the University of Ghana's Noguchi Memorial Institute for Medical Research in Accra on Wednesday 18 November.

He also opened new mRNA and protein laboratories for vaccine research at the institute. The National Vaccine Institute and Noguchi have set them up as national facilities that Ghanaian scientists from any institution can use, 3News and Daily Post Ghana reported.

The President said the DNA laboratory was needed after the military helicopter crash of 6 August 2025, when tissue recovered from the crash site had to be sent to South Africa for analysis and families waited days for results. "It actually was a day of shame for Ghana that we couldn't carry out our DNA analysis in country," he said. "That will be a thing of the past."

The laboratory will support police forensic work in cases such as rape and murder, and will also be used in paternity and inheritance disputes, he said.

On vaccines, Mr Mahama said Ghana is one of only five African countries working with mRNA technology to research and develop vaccines. He named Atlantic Life Sciences and DEK Laboratories as the two Ghanaian companies selected to develop vaccines. Five Ghanaian scientists trained in Brussels and Accra will now train others to use the mRNA laboratory.

He said the government had set aside US$1 billion for pharmaceuticals under the seventh pillar of its economic plan, to build pharmaceutical and bio-manufacturing hubs, and would spend US$46 million this year buying vaccines for child immunisation. Ghana is preparing for support from Gavi, the vaccine alliance, to end by January 2030.

At the same ceremony, the Chief Executive of the National Vaccine Institute, Dr Sodzi Sodzi-Tettey, said Ghana was "really on track" to make its first locally manufactured vaccine, a tetanus-diphtheria (Td) vaccine, in 2027. The first of three bulk substances needed to make it had arrived in the country and was at the premises of Atlantic Life Sciences, he said, according to MyJoyOnline.

He urged Ghanaians not to fear properly run clinical trials, recalling a planned Ebola vaccine trial in the Volta Region that was moved out of the country after a public scare.

Sources: President Mahama commissions DNA, vaccine research laboratories at Noguchi.

Numbers behind the story +

Figures used

  • African countries working with mRNA technology for vaccine: 5 (African countries working with mRNA technology for vaccine research, including Ghana, according to the President (President Mahama, 18 Nov 2026))
  • allocated for pharmaceuticals under the seventh pillar of: US$1 billion (allocated for pharmaceuticals under the seventh pillar of the government's economic plan (President Mahama, 18 Nov 2026))

About & Methodology · Glossary · Report or view corrections

More from StatsGH